NCT01714570View on ClinicalTrials.gov

Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia

NACompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions
FebrileNeutropeniaHematopoietic Stem Cell Transplantation
Interventions
DRUG

Piperacillin-tazobactam combination product

4.5g q6h, 5-10 days

DRUG

Imipenem

0.5g q6h, 5-10 days

Trial Locations (1)

100853

Chinese PLA general hospital, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER

NCT01714570 - Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia | Biotech Hunter | Biotech Hunter